RN7SL825P

Across TCGA pan-cancer cohorts, RN7SL825P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RN7SL825P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL825P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL825P is over-expressed in tumor.

HNSC, BRCA, and THCA are the cancer types where RN7SL825P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL825P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.113	.001	7	view →
BRCA	All	II,III,IV	+0.172	<.001	6	view →
THCA	All	All	+0.127	.001	6	view →
COAD	All	III,IV	+0.293	.003	4	view →
STAD	Male	II,III,IV	+0.120	.012	4	view →
CHOL	All	All	+0.441	.002	2	view →
LUSC	Male	III,IV	+0.392	.038	1	view →
KIRC	All	All	+0.052	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RN7SL825P–HNSC

Open the HNSC breakdown →